VYGR PEER ANALYSIS

Voyager Therapeutics Inc — metric-by-metric comparison with peers and the industry median

VYGRVoyager Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

VYGRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	VYGR	MSB	RTALB	TLX	Ind. Median
P/E	—	—	4.78	—	18.06
P/B	1.29	—	0.59●	6.38	3.62
EV/EBITDA	—	—	72.98●	120.20	15.13
P/S	6.16	31.30	6.52	3.24●	10.65

Financial Health
Metric	VYGR	MSB	RTALB	TLX	Ind. Median
Current Ratio	8.42●	—	1.21	1.43	5.90
Debt/Equity	19.9%	—	1.2%●	112.3%	10.9%
NetDebt/EBITDA	0.95	—	0.90●	13.13	1.15

Profitability
Metric	VYGR	MSB	RTALB	TLX	Ind. Median
Net Margin	-319.6%	-115.3%	136.3%●	-0.9%	-125.7%
ROE	-52.3%	-11.3%	15.1%●	-1.8%	-47.5%
ROA	-40.7%	-8.6%	13.1%●	-0.7%	-35.8%
EBITDA Margin	-308.4%	-76.6%	9.0%●	3.0%	-105.8%

Growth + Dividend
Metric	VYGR	MSB	RTALB	TLX	Ind. Median
Rev. Growth	-45.5%	410.4%●	24.0%	56.3%	5.1%
NI Growth	—	—	134.0%	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	VYGR	CDXS	ALEC	IMRX	NAUT	RNA	Ind. Median
P/E	—	—	—	—	—	—	18.06
P/B	1.29	5.46	20.56	0.00●	1.48	0.97	3.62
EV/EBITDA	—	—	—	—	—	—	15.13
P/S	6.16	3.02●	11.59	—	—	6.15	10.65

Financial Health
Metric	VYGR	CDXS	ALEC	IMRX	NAUT	RNA	Ind. Median
Current Ratio	8.42	5.36	5.25	32.45●	11.85	13.04	5.90
Debt/Equity	19.9%	168.6%	332.8%	1.8%	20.0%	1.1%●	10.9%
NetDebt/EBITDA	0.95	-0.33	1.48	-60.72●	1.32	0.65	1.15

Profitability
Metric	VYGR	CDXS	ALEC	IMRX	NAUT	RNA	Ind. Median
Net Margin	-319.6%	-41.0%●	-680.8%	—	—	-1,076.9%	-125.7%
ROE	-52.3%	-68.9%	-238.9%	-0.1%●	-33.7%	-50.7%	-47.5%
ROA	-40.7%	-24.8%	-38.7%	-0.1%●	-28.2%	-45.3%	-35.8%
EBITDA Margin	-308.4%	-28.2%●	-632.1%	—	—	-1,108.5%	-105.8%

Growth + Dividend
Metric	VYGR	CDXS	ALEC	IMRX	NAUT	RNA	Ind. Median
Rev. Growth	-45.5%	56.8%	-79.2%	-100.0%	-100.0%	312.4%●	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on VYGR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.